No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
360 (estimated)
Sponsor
University of North Carolina, Chapel Hill · Other
Who this trial is looking for
This trial is looking for patients with dementia and their caregivers to participate in a program aimed at supporting transitions from skilled nursing facilities to home or other living arrangements. Participants will be involved in activities that may help reduce caregiver stress and improve symptoms of dementia.
Are You a Good Fit for This Trial?
You may be able to join if
I can speak English
I am aiming to move to home, assisted living, or long-term care
I have been diagnosed with dementia
I have a caregiver who is willing to participate
You may not be able to join if
I am scheduled for a hospital readmission within 30 days of joining
My caregiver is a court-appointed guardian
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strai…
This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
Patients:
* Ability to speak English
* Goal of discharge to home, assisted living, or long-term care
* Diagnosis of dementia
* Having a caregiver willing to participate
Caregivers:
* Ability to speak English
* Legally authorized representative (LAR) who also provides support …
Inclusion Criteria:
Patients:
* Ability to speak English
* Goal of discharge to home, assisted living, or long-term care
* Diagnosis of dementia
* Having a caregiver willing to participate
Caregivers:
* Ability to speak English
* Legally authorized representative (LAR) who also provides support for the person with ADRD
Inclusion criteria for SNFs:
* Location within 120 miles of UNC-Chapel Hill
* Admission of at least 75 SNF patients per year
Exclusion Criteria:
Patients:
* Planned hospital readmission for procedures or treatments within 30 days post enrollment.
Caregivers:
* LAR is a court-appointed guardian.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
